Roundview Capital LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 571.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 30,087 shares of the exchange traded fund’s stock after buying an additional 25,607 shares during the period. Roundview Capital LLC’s holdings in SPDR S&P Biotech ETF were worth $3,669,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Integrity Alliance LLC. purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $723,000. Cary Street Partners Financial LLC raised its holdings in shares of SPDR S&P Biotech ETF by 36.3% in the 4th quarter. Cary Street Partners Financial LLC now owns 14,993 shares of the exchange traded fund’s stock valued at $1,828,000 after acquiring an additional 3,995 shares in the last quarter. Wellington Shields Capital Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $372,000. Capital Management Associates NY purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $732,000. Finally, Harbour Investments Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 34.7% in the 4th quarter. Harbour Investments Inc. now owns 1,017 shares of the exchange traded fund’s stock valued at $124,000 after acquiring an additional 262 shares in the last quarter.
SPDR S&P Biotech ETF Stock Up 1.3%
NYSEARCA:XBI opened at $133.35 on Wednesday. The business’s 50-day moving average price is $130.23 and its two-hundred day moving average price is $125.49. SPDR S&P Biotech ETF has a twelve month low of $78.06 and a twelve month high of $139.19. The stock has a market cap of $8.51 billion, a P/E ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
